Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Pediatric Radiology
Erschienen in:

05.01.2022 | Pediatric Body MRI

Vascular anomalies: clinical perspectives

verfasst von: Joao Guilherme Amaral, Irene Lara-Corrales

Erschienen in: Pediatric Radiology | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Vascular anomalies are classified as vascular tumors or vascular malformations according to their cellular features and biological behavior. Detailed history and clinical assessment allow for the proper clinical diagnosis of most vascular anomalies and guide the choice of imaging to evaluate them. This article discusses the general information needed from a clinical history and physical exam to formulate a diagnosis of vascular anomaly. Then, the authors review the clinical findings from the most common vascular tumors and vascular malformations.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Mulliken JB, Burrows PE, Fishman SJ (2013) Mulliken and Young’s vascular anomalies: hemangiomas and malformations, 2nd edn. Oxford University Press, New YorkCrossRef
2.
Zuniga-Castillo M, Teng CL, Teng JMC (2019) Genetics of vascular malformation and therapeutic implications. Curr Opin Pediatr 31:498–508PubMedCrossRef
3.
John P (2014) Vascular anomalies. In: Temple M, Marshalleck FE (eds) Pediatric interventional radiology: handbook of vascular and non-vascular interventions. Springer, New York, pp 177–224CrossRef
4.
Tekes A, Koshy J, Kalayci TO et al (2014) S. E. Mitchell vascular anomalies flow chart (SEMVAFC): a visual pathway combining clinical and imaging findings for classification of soft-tissue vascular anomalies. Clin Radiol 69:443–457PubMedCrossRef
5.
Anomalies ISftSoV (2018) ISSVA Classification of Vascular Anomalies ©2018 International Society for the Study of Vascular Anomalies Available at issva.​org/​classification. Accessed March 31, 2021
6.
Van Damme A, Seront E, Dekeuleneer V et al (2020) New and emerging targeted therapies for vascular malformations. Am J Clin Dermatol 21:657–668PubMedCrossRef
7.
Hoornweg MJ, Smeulders MJ, Ubbink DT, van der Horst CM (2012) The prevalence and risk factors of infantile haemangiomas: a case-control study in the Dutch population. Paediatr Perinat Epidemiol 26:156–162PubMedCrossRef
8.
North PE, Waner M, Mizeracki A, Mihm MC Jr (2000) GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 31:11–22PubMedCrossRef
9.
Hemangioma Investigator Group, Haggstrom AN, Drolet BA et al (2007) Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 150:291–294CrossRef
10.
Amir J, Metzker A, Krikler R, Reisner SH (1986) Strawberry hemangioma in preterm infants. Pediatr Dermatol 3:331–332PubMedCrossRef
11.
Braun V, Prey S, Gurioli C et al (2020) Congenital haemangiomas: a single-centre retrospective review. BMJ Paediatr Open 4:e000816
12.
13.
Chang LC, Haggstrom AN, Drolet BA et al (2008) Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 122:360–367PubMedCrossRef
14.
Chamlin SL, Haggstrom AN, Drolet BA et al (2007) Multicenter prospective study of ulcerated hemangiomas. J Pediatr 151:684–689, 689e681
15.
Couto RA, Maclellan RA, Zurakowski D et al (2012) Infantile hemangioma: clinical assessment of the involuting phase and implications for management. Plast Reconstr Surg 130:619–624PubMedCrossRef
16.
Metry DW, Haggstrom AN, Drolet BA et al (2006) A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications. Am J Med Genet A 140:975–986PubMedCrossRef
17.
Frieden IJ, Reese V, Cohen D (1996) PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 132:307–311PubMedCrossRef
18.
Metry D, Heyer G, Hess C et al (2009) Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics 124:1447–1456PubMedCrossRef
19.
20.
21.
Iacobas I, Burrows PE, Frieden IJ et al (2010) LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies. J Pediatr 157:795–801PubMedCrossRef
22.
Hughes JA, Hill V, Patel K et al (2004) Cutaneous haemangioma: prevalence and sonographic characteristics of associated hepatic haemangioma. Clin Radiol 59:273–280PubMedCrossRef
23.
24.
Restrepo R, Palani R, Cervantes LF et al (2011) Hemangiomasrevisited: the useful, the unusual and the new. Part 1: overview and clinicaland imaging characteristics. Pediatr Radiol 41:895–904PubMedCrossRef
25.
Berenguer B, Mulliken JB, Enjolras O et al (2003) Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol 6:495–510PubMedCrossRef
26.
Krol A, MacArthur CJ (2005) Congenital hemangiomas: rapidly involuting and noninvoluting congenital hemangiomas. Arch Facial Plast Surg 7:307–311PubMedCrossRef
27.
Mulliken JB, Enjolras O (2004) Congenital hemangiomas and infantile hemangioma: missing links. J Am Acad Dermatol 50:875–882PubMedCrossRef
28.
Patel A, De Leacy R, Berenstein A (2019) Angiographic and Clinical Features of Noninvoluting Congenital Hemangiomas. AJNR Am J Neuroradiol 40:845–848PubMedPubMedCentralCrossRef
29.
Debelenko LV, Perez-Atayde AR, Mulliken JB et al (2005) D2–40 immunohistochemical analysis of pediatric vascular tumors revealspositivity in kaposiform hemangioendothelioma. Mod Pathol 18:1454–1460PubMedCrossRef
30.
Putra J, Gupta A (2017) Kaposiform haemangioendothelioma: a review with emphasis on histological differential diagnosis. Pathology 49:356–362PubMedCrossRef
31.
Croteau SE, Liang MG, Kozakewich HP et al (2013) Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr 162:142–147PubMedCrossRef
32.
33.
Ji Y, Yang K, Peng S et al (2018) Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon. Br J Dermatol 179:457–463PubMed
34.
Boccara O, Fraitag S, Lasne D et al (2016) Kaposiform Haemangioendothelioma-spectrum Lesions with Kasabach-Merritt Phenomenon: Retrospective Analysis and Long-term Outcome. Acta Derm Venereol 96:77–81PubMedCrossRef
35.
Enjolras O, Mulliken JB, Wassef M et al (2000) Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 42:225–235PubMedCrossRef
36.
Rozas-Munoz E, Frieden IJ, Roe E et al (2016) Vascular Stains: Proposal for a Clinical Classification to Improve Diagnosis and Management. Pediatr Dermatol 33:570–584PubMedCrossRef
37.
Cooke-Barber J, Kreimer S, Patel M et al (2020) Venous malformations. Semin Pediatr Surg 29:150976
38.
Legiehn GM, Heran MK (2010) A Step-by-Step Practical Approach to Imaging Diagnosis and Interventional Radiologic Therapy in Vascular Malformations. Semin Intervent Radiol 27:209–231PubMedPubMedCentralCrossRef
39.
Legiehn GM, Heran MK (2008) Venous malformations: classification, development, diagnosis, and interventional radiologic management. Radiol Clin North Am 46:545–597, viCrossRef
40.
Acord M, Srinivasan AS, Cahill AM (2016) Percutaneous treatment of lymphatic malformations. Tech Vasc Interv Radiol 19:305–311PubMedCrossRef
41.
42.
Shergill A, John P, Amaral JG (2012) Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy. Pediatr Radiol 42:1080–1088PubMedCrossRef
43.
Dubois J, Thomas-Chausse F, Soulez G (2019) Common (cystic) lymphatic malformations: current knowledge and management. Tech Vasc Interv Radiol 22:100631
44.
Elluru RG, Balakrishnan K, Padua HM (2014) Lymphatic malformations: diagnosis and management. Semin Pediatr Surg 23:178–185PubMedCrossRef
45.
Kulungowski AM, Patel M (2020) Lymphatic malformations. Semin Pediatr Surg 29:150971
46.
Bloom DC, Perkins JA, Manning SC (2004) Management of lymphatic malformations. Curr Opin Otolaryngol Head Neck Surg 12:500–504PubMedCrossRef
47.
Kalwani NM, Rockson SG (2021) Management of lymphatic vascular malformations: a systematic review of the literature. J Vasc Surg Venous Lymphat Disord
48.
49.
Timbang MR, Richter GT (2020) Update on extracranial arteriovenous malformations: A staged multidisciplinary approach. Semin Pediatr Surg 29:150965
50.
Finn MC, Glowacki J, Mulliken JB (1983) Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 18:894–900PubMedCrossRef
51.
Wooderchak-Donahue WL, Johnson P, McDonald J et al (2018) Expanding the clinical and molecular findings in RASA1 capillary malformation-arteriovenous malformation. Eur J Hum Genet 26:1521–1536PubMedPubMedCentralCrossRef
52.
Larralde M, Abad ME, Luna PC et al (2014) Capillary malformation-arteriovenous malformation: a clinical review of 45 patients. Int J Dermatol 53:458–461PubMedCrossRef
53.
Revencu N, Boon LM, Mendola A et al (2013) RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation. Hum Mutat 34:1632–1641PubMedCrossRef
54.
Eng W, Hammill AM, Adams DM (2020) Overgrowth syndromes and new therapies. Semin Pediatr Surg 29:150974
55.
Banzic I, Brankovic M, Maksimovic Z, Davidovic L, Markovic M, Rancic Z (2017) Parkes Weber syndrome-Diagnostic and management paradigms: A systematic review. Phlebology 32:371–383PubMedCrossRef
56.
57.
Martinez-Lopez A, Blasco-Morente G, Perez-Lopez I et al (2017) CLOVES syndrome: review of a PIK3CA-related overgrowth spectrum (PROS). Clin Genet 91:14–21PubMedCrossRef
58.
Alomari AI, Spencer SA, Arnold RW et al (2014) Fibro-adipose vascular anomaly: clinical-radiologic-pathologic features of a newly delineated disorder of the extremity. J Pediatr Orthop 34:109–117PubMedCrossRef
59.
Wang KK, Glenn RL, Adams DM et al (2020) Surgical Management of Fibroadipose Vascular Anomaly of the Lower Extremities. J Pediatr Orthop 40:e227–e236PubMedCrossRef
60.
Amarneh M, Shaikh R (2020) Clinical and imaging features in fibro-adipose vascular anomaly (FAVA). Pediatr Radiol 50:380–387PubMedCrossRef
61.
Shaikh R, Alomari AI, Kerr CL et al (2016) Cryoablation in fibro-adipose vascular anomaly (FAVA): a minimally invasive treatment option. Pediatr Radiol 46:1179–1186PubMedCrossRef
62.
63.
Yehia L, Keel E, Eng C (2020) The Clinical Spectrum of PTEN Mutations. Annu Rev Med 71:103–116PubMedCrossRef
64.
SmpokouP Fox VL, Tan WH (2015) PTEN hamartoma tumour syndrome: early tumourdevelopment in children. Arch Dis Child 100:34–37CrossRef
Metadaten
Titel
Vascular anomalies: clinical perspectives
verfasst von
Joao Guilherme Amaral
Irene Lara-Corrales
Publikationsdatum
05.01.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 2/2022
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-021-05260-z

Weitere Artikel der Ausgabe 2/2022

Contrast-enhanced body magnetic resonance angiography: how we do it

  • Pediatric Body MRI

Basics of magnetic resonance imaging and quantitative parameters T1, T2, T2*, T1rho and diffusion-weighted imaging

  • Pediatric Body MRI

Signal intensity patterns in health and disease: basics of abdominal magnetic resonance imaging in children

  • Pediatric Body MRI

Non-contrast magnetic resonance angiography/venography techniques: what are my options?

  • Pediatric Body MRI

Radial sequences and compressed sensing in pediatric body magnetic resonance imaging

  • Pediatric Body MRI

Magnetic resonance imaging of the pediatric mediastinum: updates, tips and tricks

  • Pediatric Body MRI

Neu im Fachgebiet Radiologie

Stumme Schlaganfälle − ein häufiger Nebenbefund im Kopf-CT?

In 4% der in der Notfallambulanz initiierten zerebralen Bildgebung sind „alte“ Schlaganfälle zu erkennen. Gar nicht so selten handelt es sich laut einer aktuellen Studie dabei um unbemerkte Insulte. Bietet sich hier womöglich die Chance auf ein effektives opportunistisches Screening?

Stören weiße Wände und viel Licht die Bildqualitätskontrolle?

Wenn es darum geht, die technische Qualität eines Mammogramms zu beurteilen, könnten graue Wandfarbe und reduzierte Beleuchtung im Bildgebungsraum von Vorteil sein. Darauf deuten zumindest Ergebnisse einer kleinen Studie hin. 

PMBCL mit CMR: Radiatio kann ohne Risiko weggelassen werden

Patienten mit primär mediastinalem B-Zell-Lymphom (PMBCL), die nach der Induktionstherapie eine komplette metabolische Remission (CMR) erreichen und keine konsolidierende Bestrahlung erhalten, müssen offenbar keine Überlebensnachteile fürchten.

Hypoxisch-ischämische Enzephalopathie: Indikatoren für eine ungünstige Prognose

Eine US-amerikanische Studie widmete sich der Identifizierung prognostischer Parameter bei Neugeborenen mit mittelschwerer oder schwerer hypoxisch-ischämischer Enzephalopathie (HIE), die mittels induzierter Hypoxie behandelt wurden. Besonders im 24-Stunden-EEG und der MRT konnten relevante Hinweise gefunden werden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise